FRISINA, Nicola
 Distribuzione geografica
Continente #
EU - Europa 7.853
NA - Nord America 6.542
AS - Asia 3.750
SA - Sud America 1.254
AF - Africa 93
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.501
Nazione #
US - Stati Uniti d'America 6.413
RU - Federazione Russa 4.004
SG - Singapore 1.477
CN - Cina 1.271
BR - Brasile 1.077
SE - Svezia 959
IE - Irlanda 917
DE - Germania 564
UA - Ucraina 398
HK - Hong Kong 391
FI - Finlandia 257
FR - Francia 236
VN - Vietnam 222
GB - Regno Unito 205
IT - Italia 145
IN - India 90
CA - Canada 67
AR - Argentina 54
TR - Turchia 45
PL - Polonia 41
BD - Bangladesh 38
IQ - Iraq 33
EC - Ecuador 31
VE - Venezuela 31
MX - Messico 30
BE - Belgio 29
ZA - Sudafrica 26
JP - Giappone 23
CZ - Repubblica Ceca 19
PK - Pakistan 18
CO - Colombia 16
IR - Iran 16
MA - Marocco 16
UY - Uruguay 14
AT - Austria 13
ID - Indonesia 13
UZ - Uzbekistan 13
KE - Kenya 11
NL - Olanda 11
NP - Nepal 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
EG - Egitto 10
JO - Giordania 10
ES - Italia 9
PE - Perù 9
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
CR - Costa Rica 7
MY - Malesia 7
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LT - Lituania 6
PA - Panama 6
BG - Bulgaria 5
BO - Bolivia 5
IL - Israele 5
OM - Oman 5
PY - Paraguay 5
SA - Arabia Saudita 5
SN - Senegal 5
AL - Albania 4
CH - Svizzera 4
JM - Giamaica 4
RO - Romania 4
AU - Australia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RS - Serbia 3
BN - Brunei Darussalam 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
GI - Gibilterra 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 19.490
Città #
Moscow 1.154
Dublin 917
Jacksonville 848
Ashburn 840
Singapore 785
Chandler 778
Dallas 617
Nyköping 456
Beijing 436
Hong Kong 389
San Jose 334
The Dalles 197
Munich 177
Los Angeles 164
Cambridge 150
Princeton 150
Lauterbourg 141
Medford 141
Des Moines 120
Ann Arbor 114
Boardman 108
New York 106
Dearborn 86
São Paulo 74
Ho Chi Minh City 72
Helsinki 70
Buffalo 64
Lancaster 61
Bremen 52
Hanoi 52
Tianjin 51
Shenyang 48
Guangzhou 47
Jinan 47
Wilmington 47
Woodbridge 45
Santa Clara 41
Frankfurt am Main 39
Turku 34
Redondo Beach 33
Zhengzhou 32
Belo Horizonte 30
Rio de Janeiro 30
Brussels 28
Hebei 28
Orem 27
San Mateo 27
Nanjing 26
Houston 24
Warsaw 24
Council Bluffs 23
Turin 23
Montreal 22
Pune 22
Taizhou 22
Haikou 21
Shanghai 21
Chennai 20
Hangzhou 20
Johannesburg 20
Tokyo 20
Boston 19
Ningbo 19
Augusta 18
Düsseldorf 18
Ottawa 18
San Francisco 18
Curitiba 17
Poplar 17
Porto Alegre 17
Seattle 17
Brno 16
Atlanta 15
Campinas 15
Denver 15
London 15
Mumbai 15
Stockholm 15
Chicago 14
Quito 14
Baghdad 13
Brooklyn 13
Changsha 13
Lanzhou 13
Taiyuan 13
Guayaquil 12
Nanchang 12
Santo André 12
Falls Church 11
Jiaxing 11
Shenzhen 11
Amman 10
Ardabil 10
Brasília 10
Istanbul 10
Leawood 10
Nuremberg 10
Recife 10
Tashkent 10
Da Nang 9
Totale 11.130
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 292
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 233
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 220
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 205
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 204
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 201
AQP1 in red blood cells of uremic patients during hemodialytic treatment 198
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 196
Aquaporin-2 water channels in spontaneously hypertensive rats 195
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 191
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 189
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 188
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 186
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 186
Does captopril have a direct pro-apoptotic effect? 185
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 184
Are there potential non-lipid-lowering uses of statins in the kidney? 184
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 182
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 182
Cardiovascular effects of raloxifene hydrochloride 182
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 179
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 176
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 175
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 175
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 172
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 171
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 168
A trigonometric approximation method for the monostatic radar cross section 168
Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future 168
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 167
Recombinant erythropoietin and hypertension 164
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 163
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 163
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 163
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 162
Effetti dell'alendronato sul Sister Chromatid Exchanges (SCE) in pazienti con osteoporosi post-menopausale (dati preliminari). 158
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 156
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 155
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 154
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 153
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 152
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 151
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 149
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 149
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 149
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 148
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 147
Oxidative stress and uremia 147
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 146
Therapy with vasopressin receptor antagonists: the aquaretics 146
Statins in the prevention of cardiovascular events in patients with renal failure. 145
Statins in nephrotic syndrome: a new weapon against tissue injury. 145
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 145
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 144
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 144
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 144
EFFICACY AND TOLERABILITY OF AURANOFIN IN RHEUMATOID-ARTHRITIS - 2 YEARS FOLLOW-UP 144
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 144
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 143
Increased indexes of thrombin activation in advanced stages of hypertension 141
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 141
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 141
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 141
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 140
Erythropoietin and the brain: from neurodevelopment to neuroprotection 140
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 140
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 140
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 139
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 139
Cardiovascular remodeling, apoptosis, and drugs 139
Statins and progressive renal disease 139
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 136
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 135
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 134
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 133
Kidney aging: From phenotype to genetics 131
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 131
The pleiotropic effects of erythropoietin in the central nervous system 129
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 128
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 126
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 126
Management of patients after renal graft loss: an open question for nephrologists. 126
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 124
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 123
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 119
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 118
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 117
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 115
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 111
Recombinant human erythropoietin (rHuEPO): More than just the correction of uremic anemia 110
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 109
Plasma and erythrocyte magnesium concentrations in essential arterial hypertension 107
Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits? 107
Flushing due to calcitonin and the opioid system 105
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 105
Effect of Growth Factors on the Potassium-Calcium induced efflux in vitro in wlole erythrocytes from hypertensive and pregnant subjects with gestation hypertension 104
Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration 103
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 102
Totale 15.317
Categoria #
all - tutte 63.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/20221.213 5 263 13 26 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/20253.105 60 25 46 189 114 132 92 695 762 188 306 496
2025/20268.826 437 650 592 592 661 1.943 1.010 1.137 1.226 326 124 128
Totale 19.562